269 results on '"Pehlivan, Berrin"'
Search Results
2. Comment on Konishi et al.
3. Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers
4. Predictive potential of pan-immune-inflammation value / hemoglobin index as biomarker for osteoradionecrosis risk in locally advanced nasopharyngeal carcinomas
5. Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients
6. High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer
7. In reply to Cheng et al. (DOI: 10.1186/s13550-023-00965-8)
8. Valero’s host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients
9. The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy
10. Radiation Therapy for Lung Cancer in Elderly
11. Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients
12. Radiotherapy and Dental Implant Applications in Patients with Head and Neck Cancer
13. Oral Microbiota: As a Cause of Head and Neck Cancers
14. Preoperative Radiosurgical Management of Brain Metastases: Evidence and Challenges
15. Combined Stereotactic Radiosurgery and Immune Checkpoint Inhibitors for the Treatment of Brain Metastasis
16. Definitions of Radiation-induced Trismus in Head and Neck Cancer: Current Concepts and Controversies
17. Challenges in the Radiological Diagnosis of Osteoradionecrosis of the Jaw in Head and Neck Cancer Patients
18. Assessment of the Impact of Osteoradionecrosis on Quality-of-Life Measures in Patients with Head and Neck Cancer
19. Global immune-nutrition-inflammation index as a novel comprehensive biomarker in predicting the radiation-induced trismus rates in locally advanced nasopharyngeal carcinoma patients
20. Radiation-induced Trismus and Related Measures of Patient Life Quality
21. Radiation- Induced Trismus: A Concise Review of Pathogenesis, Prevention and Management
22. Persistent Inflammation as a Cause of Severe Late Complications in Chemoradiotherapy-treated Head and Neck Cancer Patients
23. Radiation Therapy for Lung Cancer in Elderly
24. Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial
25. The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients
26. Letter to the Editor: Local Treatment of Children Suffering From Parameningeal Rhabdomyosarcoma - A Retrospective Single-Center Study From China
27. A Review on Brain Metastases Prognostic Scoring Systems
28. Low hemoglobin levels predict increased radiation‐induced trismus rates in nasopharyngeal cancer.
29. Comment on Konishi et al.
30. Stereotactic Radiosurgery Techniques and Quality Assurance for Brain Metastases
31. Management of Brain Metastases with Preoperative Radiosurgery
32. A Comprehensive Review on Tumor Cavity Stereotactic Radiosurgery for Resected Brain Metastases
33. Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neck
34. The Prognostic Value of the Novel Global Immune-Nutrition-Inflammation Index (GINI) in Stage IIIC Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy
35. A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer
36. The predictive usefulness of the novel “combined hemoglobin‐to‐platelet ratio and maximum mouth opening index” on prevalence of radiation induced trismus in patients with nasopharyngeal cancer
37. Low hemoglobin levels predict increased radiation‐induced trismus rates in nasopharyngeal cancer
38. Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors
39. Letter to the Editor: Radiotherapy Increases aMMP-8 Levels and Neutrophil/Lymphocyte Ratio Rapidly in Head and Neck Cancer Patients: A Pilot Study
40. Initial neutrophil‐to‐lymphocyte ratio predicts radiation‐induced trismus in parotid gland cancer.
41. Hemoglobin‐to‐platelet ratio in predicting the incidence of trismus after concurrent chemoradiotherapy.
42. Contributors
43. Safety and Palliative Efficacy of Single-Dose 8-Gy Reirradiation for Painful Local Failure in Patients With Stage IV Non-Small Cell Lung Cancer Previously Treated With Radical Chemoradiation Therapy
44. Initial neutrophil‐to‐lymphocyte ratio predicts radiation‐induced trismus in parotid gland cancer
45. Comment on "Impact of pretreatment quality of life on tolerance and survival outcome in head and neck cancer patients undergoing definitive CCRT".
46. Hemoglobin‐to‐platelet ratio in predicting the incidence of trismus after concurrent chemoradiotherapy
47. Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas
48. High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients
49. Temporal Lobe Toxicity Analysis After Proton Radiation Therapy for Skull Base Tumors
50. Impact of Prophylactic Cranial Irradiation Timing on Brain Relapse Rates in Patients With Stage IIIB Non–Small-Cell Lung Carcinoma Treated With Two Different Chemoradiotherapy Regimens
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.